One major reason is that GSIs have activity against T-ALL with NOTCH1 mutations but not those with PTEN deficiency and activation of PI3K-AKT signaling [30], as well as constitutive MYC expression [139]. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.